Contact
Please use this form to send email to PR contact of this press release:
Human medicines European public assessment report (EPAR): Abrysvo, Respiratory syncytial virus vaccines, Respiratory Syncytial Virus Infections, Date of authorisation: 23/08/2023, Status: Authorised
TO: